Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China · Delayed Price · Currency is CNY

12.70

-0.28 (-2.16%)

Jun 11, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Industry	1.96B	2.12B	2.10B	1.87B	-
Industry Growth	-7.38%	1.10%	12.27%	-	-
Commodity Circulation (Commercial)	49.90M	41.25M	46.19M	48.85M	43.87M
Commodity Circulation (Commercial) Growth	20.97%	-10.69%	-5.45%	11.35%	-0.25%
Other Business	31.37M	31.75M	27.41M	42.15M	18.38M
Other Business Growth	-1.18%	15.84%	-34.98%	129.37%	131.74%
Chinese Patent Medicine (Industry)	-	-	-	-	1.59B
Chinese Patent Medicine (Industry) Growth	-	-	-	-	11.49%
Other (Industrial)	-	-	-	-	88.19M
Other (Industrial) Growth	-	-	-	-	0.54%
Total	2.05B	2.19B	2.17B	1.96B	1.74B
Total Growth	-6.76%	1.03%	10.81%	12.55%	11.15%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	2.02B	2.18B	2.16B	1.95B	1.73B
China Growth	-7.57%	1.06%	10.81%	12.52%	11.80%
Overseas	28.87M	11.84M	12.35M	11.12M	9.45M
Overseas Growth	143.90%	-4.14%	10.98%	17.72%	-46.04%
Total	2.05B	2.19B	2.17B	1.96B	1.74B
Total Growth	-6.76%	1.03%	10.81%	12.55%	11.15%

Source: S&P Global Market Intelligence.